Kessler, L. (2015) “A retrospective safety and efficacy analysis of the first patients treated with eribulin for metastatic breast cancer in Stockholm, Sweden”, Acta Oncologica, 54(4), pp. 527–534. doi: 10.3109/0284186X.2014.973063.